Therasource LLC

UEI
NEHDGYYET4V5
CAGE
480A9
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • Minority Owned Business
  • For Profit Organization
  • Asian-Pacific American Owned
  • Limited Liability Company
Entity structure
Partnership or Limited Liability Partnership
NAICS codes registered in SAM.gov
SAM.gov registration date
Website
therasourceinc.com
SIC code
28 Chemical & Allied Products

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Therasource LLC's 5 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Ecirp-neutralizing MAB for acute lung injury in sepsis - project description: the primary objective of this project is… Grant · R43AI162111 National Institute of Allergy and Infectious Diseases $519,150
A new therapy for acute kidney injury Grant · R43DK120175 National Institute of Diabetes and Digestive and Kidney Diseases $299,999
Preclinical development of a novel small molecule drug for sepsis Grant · R41GM123858 National Institute of General Medical Sciences $333,340
A novel recombinant protein as an effective therapy for acute kidney injury Grant · R43DK108501 National Institutes of Health $335,318
Rhmfg-E8 as an effective adjuvant therapy for hemorrhagic shock Grant · R44HL129543 National Heart Lung and Blood Institute $4,956,840

Quick answers

What is Therasource LLC's UEI?

Therasource LLC's Unique Entity ID (UEI) in SAM.gov is NEHDGYYET4V5.

What is Therasource LLC's CAGE code?

Therasource LLC's CAGE code is 480A9.

What is Therasource LLC's primary NAICS code?

Therasource LLC's primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Is Therasource LLC registered in SAM.gov?

Therasource LLC's SAM.gov registration expired on March 16, 2024.

What is Therasource LLC's most recent federal award?

Therasource LLC's most recent federal grant award is Ecirp-neutralizing MAB for acute lung injury in sepsis - project description: the primary objective of this project is… (R43AI162111), from National Institute of Allergy and Infectious Diseases, on June 1, 2022.

On GovTribe

See Therasource LLC's full federal record

  • Federal contract awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login